The risk of lymphoma has been reported to be higher among patients with IBD receiving thiopurines. In a recent study, researchers sought to further investigate this risk among patients with IBD with various...
The US Food and Drug Administration has approved a combination intravenous treatment for follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.
The FDA has posted a correction for this press release: "The notice posted to the Hematology/Oncology Approvals web page yesterday afternoon regarding an approval for the treatment of Hodgkin lymphoma...
New research investigated whether chronic hepatitis B or C virus infection were associated with increased incidence of non-Hodgkin lymphoma in patients also infected with human immunodeficiency virus...
